# Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction

> **NCT01468389** · PHASE3 · UNKNOWN · sponsor: **The Affiliated Hospital of the Chinese Academy of Military Medical Sciences** · enrollment: 300 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT01468389
- **Lead sponsor:** The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2011-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468389, "Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01468389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*